Gosney JR, Travis WD. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia in WHO Classification of Tumors, Pathology and Genetics of Tumors of Lung, Pleura, Thymus and Heart. IARC Press Lyon 2004; 76-77
Aguaya SM, Miller YE, Waldron JA Jr., et al. Idiopathic Diffuse Hyperplasia of Pulmonary Neuroendocrine cells and Airways disease. N Engl J Med 1992;327:1285-1288
Carter D, Patchefsky AS. Tumors and Tumor-like Lesions of the Lung. Philadelphia PA: WB.Saunders1998.
Colby TV, Koss MN, Travis WD. Tumors of the Lower Respiratory Tract. Atlas of tumor Pathology 1995;(13): 290-294
Churg A, Warnock ML . Pulmonary tumorlet-A Form of Peripheral Carcinoid. Cancer 1976;37:1469-1477
Arioglu E, Doppman J, Gomes M., et al.Cushing Sym- drome Caused by Corticotropin Secretion by Pulmonary Tumorlet. N Engl J Med 1998;339(13):883-886
Cameron CM, Roberts F, Connell J, et al. Diffuse Idiopathic Pulmonary Neuroendocrine cell Hyperplasia: an unusual cause of cyclical ectopic adrenocorticotro- phic symdrome. Br. J Radiology 2011;(84):14-17
Warth A, Hepel E, Schnähl A, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in association with an adenocarcinoma: a case report. J Med Case Reports 2008,2:21
Masuk H, Satoh H, Miyazaki K, et al. Pulmonary sequestration with elevated serum level of Progastrin – releasing Peptide, Intern Med 2008;47(3):157-160
Lachanas E, Spartalis ED, Pavlopoulos D, et al. Tumor- lets and carcinoiod secondary to congenital broncho- Oesophageal fistula. Pneumon 2008;21(3):250-253
Vansteenkiste JF, Stroobant SS. Lung Cancer. PET and PET/CT in Oncology editor P. OEHR, H.-J.B IERSACK, RE Colerman. 2003;(15):148-150
Ginsberg MS, Akin O, Berger DM, et al. Pulmonary tumorlets: CT Findings, AJR 2004;183:293-296
